📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Developing a Bayesian adaptive design for a phase I clinical trial: a case study for a novel HIV treatment. (2017)

First Author: Mason AJ

Attributed to: Developmental Clinical Studies - A Phase I study of a novel peptide fusion inhibitor for the treatment of chronic HIV infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/sim.7169

PubMed Identifier: 27891651

Publication URI: http://europepmc.org/abstract/MED/27891651

Type: Journal Article/Review

Volume: 36

Parent Publication: Statistics in medicine

Issue: 5

ISSN: 0277-6715